David Heber - Concepedia

Author

David Heber

University of California, Los Angeles

Also Known As

D Heber, D. HEBER, D. Heber, D. Phillips, DAVID HEBER, David Heber

389

Publications

25.9K

Citations

H-Index

216

Concepts

All Affiliations

University of California, Los Angeles UCLA Medical Center Harbor–UCLA Medical Center Cedars-Sinai Medical Center

About

David Heber is an author at University of California, Los Angeles specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	58	106	12.7K
2	Health Sciences	16	19	1.7K
3	Engineering	2	2	222
4	Natural Sciences	1	1	26
5	Nursing	1	1	165

David Heber

179

Publications

23.6K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice N.P. Seeram, Susan Henning, Muraleedharan G. Nair, The Journal of Nutritional Biochemistry MedicineAntioxidant ActivitiesPhytochemicalPomegranate JuicePhytochemistry	2005	1.1K
Low-Fat Dietary Pattern and Risk of Cardiovascular Disease Barbara V. Howard, Linda Van Horn, Judith Hsia, JAMA	2006	1.1K
Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat Michael Davidson, Jonathan Hauptman, Mario DiGirolamo, JAMA	1999	941
Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer Ross L. Prentice, Bette J. Caan, Rowan T. Chlebowski, JAMA	2006	822
Ligands for peroxisome proliferator-activated receptorγ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells <i>in vitro</i> and in BNX mice Elena Elstner, Carsten Müller‐Tidow, Kozo Koshizuka, Proceedings of the National Academy of Sciences	1998	795
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Pomegranate Juice, Total Pomegranate Ellagitannins, and Punicalagin Suppress Inflammatory Cell Signaling in Colon Cancer Cells Lynn S. Adams, Navindra P. Seeram, Bharat B. Aggarwal, Journal of Agricultural and Food Chemistry	2006	526
Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline David Heber, Frank L. Greenway, Lee M. Kaplan, The Journal of Clinical Endocrinology & Metabolism	2010	510
Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer Allan J. Pantuck, John T. Leppert, Nazy Zomorodian, Clinical Cancer Research	2006	460

Page 1